Order Article Reprints

Terrenato I, Ercolani C, Di Benedetto A, Gallo E, Melucci E, Casini B, Rollo F, Palange A, Visca P, Pescarmona E, et al. A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting. Cancers. 2022; 14(12):2971. https://doi.org/10.3390/cancers14122971

Terrenato, Irene, Cristiana Ercolani, Anna Di Benedetto, Enzo Gallo, Elisa Melucci, Beatrice Casini, Francesca Rollo, Aldo Palange, Paolo Visca, Edoardo Pescarmona, and et al. 2022. "A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting" Cancers 14, no. 12: 2971. https://doi.org/10.3390/cancers14122971

Terrenato, I., Ercolani, C., Di Benedetto, A., Gallo, E., Melucci, E., Casini, B., Rollo, F., Palange, A., Visca, P., Pescarmona, E., Melis, E., Gallina, F., Sacconi, A., Cecere, F. L., Landi, L., Cappuzzo, F., Ciliberto, G., & Buglioni, S. (2022). A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting. Cancers, 14(12), 2971. https://doi.org/10.3390/cancers14122971